Yonsei Med J.  2019 Apr;60(4):399-400. 10.3349/ymj.2019.60.4.399.

Genetic Data Are a Prerequisite for Interpreting Clinical and Muscle Biopsy Findings in MELAS

• Finsterer

• KMID: 2450197
• DOI: http://doi.org/10.3349/ymj.2019.60.4.399

Abstract

No abstract available.

MeSH Terms

Biopsy*
MELAS Syndrome*

Reference

1. Baek MS, Kim SH, Lee YM. The usefulness of muscle biopsy in initial diagnostic evaluation of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Yonsei Med J. 2019; 60:98–105.

2. El-Hattab AW, Almannai M, Scaglia F. MELAS. In : Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle;1993-2018. accessed on 2019 February. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1233/.

3. Poulton J, Finsterer J, Yu-Wai-Man P. Genetic counselling for maternally inherited mitochondrial disorders. Mol Diagn Ther. 2017; 21:419–429.

4. Mezuki S, Fukuda K, Matsushita T, Fukushima Y, Matsuo R, Goto YI, et al. Isolated and repeated stroke-like episodes in a middle-aged man with a mitochondrial ND3 T10158C mutation: a case report. BMC Neurol. 2017; 17:217.

5. Finsterer J. Toxicity of Antiepileptic Drugs to Mitochondria. Handb Exp Pharmacol. 2017; 240:473–488.